The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic

Insights

Unexpected antibody activity against Neisseria meningitidis group A (MenA) was found in patients with other bacterial infections. This non-specific immune response differed from true MenA infections and vaccine responses.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Bacterial meningitis remains a significant global health concern.
  • Accurate diagnosis of bacterial meningitis relies on identifying the causative pathogen and host immune response.
  • Non-specific antibody cross-reactivity can complicate diagnostic interpretations.

Purpose of the Study:

  • To investigate an observed rise in antibody activity against Neisseria meningitidis group A (MenA) capsular polysaccharide in patients with non-MenA bacteraemic infections.
  • To characterize the nature of this non-specific antibody response and differentiate it from specific immune reactions.

Main Methods:

  • Analysis of acute and convalescent phase sera from patients with various bacteraemic and non-bacteraemic diseases.
  • Measurement of antibody binding activity to MenA capsular polysaccharide using radioactive antigen.
  • Characterization of antibody immunoglobulin classes (A, G, M) and avidity.
  • Inhibition assays using N-acetylmannosamine to assess antibody specificity.

Main Results:

  • An unexpected increase in anti-MenA antibody activity was detected in 59/292 patients with infections caused by other bacteria (e.g., H. influenzae, S. pneumoniae).
  • This non-specific reactivity was absent in non-bacteraemic conditions and following certain vaccinations.
  • The 'unspecific' antibodies were of IgA, IgG, and IgM classes, exhibited lower avidity, and were significantly inhibited by N-acetylmannosamine.

Conclusions:

  • A non-specific antibody response against Neisseria meningitidis group A capsular polysaccharide can occur during other bacterial infections.
  • This phenomenon highlights the potential for cross-reactivity in antibody-based diagnostics.
  • The distinct inhibition profile by N-acetylmannosamine suggests a different epitope or binding mechanism compared to specific anti-MenA antibodies.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...